Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Allergies - Research on allergies reported by scientists at Charite University
Allergies - Studies from P.J. Bousquet et al provide new data on allergies
Asthma - Findings in asthma reported from University of Aberdeen
Asthma - New asthma research has been reported by E.R. Sutherland et al
Asthma - Reports outline asthma research from University of Ferrara
Asthma - Research on asthma detailed by scientists at Wake Forest University
Asthma - Studies from S.P. Jariwala and co-authors have provided new information about asthma
Asthma - Studies from University of Nottingham have provided new data on asthma
Asthma - Studies in the area of asthma reported from M. Pedrosa and co-researchers
Cardiology - Study results from B.K. Harvey et al provide new insights into neurotoxicology
Dermatomyositis - Reports by O. Krystufkova and co-researchers describe recent advances in dermatomyositis
Drug Resistance - Research data from E. Pitsouni and colleagues update understanding of drug resistance
Life Sciences - Research from Queen's University provides new data about life sciences
Lung Disease - Researchers from Emory University report details of new studies and findings in the area of lung disease
Non-Small Cell Lung Cancer - Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
Pneumonia - New findings from Medical University of Vienna in the area of pneumonia published
Pneumonia - Reports on pneumonia findings from C.M. Luna and co-researchers provide new insights
Pulmonary Hypertension - Findings from Harvard University broaden understanding of pulmonary hypertension
Pulmonary Hypertension - Reports summarize pulmonary hypertension study results from C.F. Barnett and co-researchers
Pulmonary Hypertension - Research reports on pulmonary hypertension from J. Mittendorf and colleagues provide new insights
Pulmonary Hypertension - Researchers from Alfred Hospital detail new studies and findings in the area of pulmonary hypertension
Pulmonary Hypertension - Studies from I. Falcaopires and colleagues reveal new findings on pulmonary hypertension
Radiation Pneumonitis - Studies conducted at G.R. Borst et al on radiation pneumonitis recently published
Tuberculosis - Data from Emory University, Medical Department provide new insights into tuberculosis
Tuberculosis - Research reports from J. Moreira and co-authors provide new insights into tuberculosis
Anti-synthetase Syndrome Therapy - Investigators at Rikshospitalet University, Department of Rheumatology target anti-synthetase syndrome therapy
Hepatocellular Cancer Prevention - Research from G. Belli and co-researchers in the area of hepatocellular cancer prevention published
Hypertension - Scientists at University Hospital publish new data on hypertension
Inflammation - Research from University of Edinburgh, Queen's Medical Research Institute in the area of inflammation described
Lupus Nephritis Therapy - Findings from National University of Singapore, Department of Medicine provide new insights into lupus nephritis therapy
Myeloma Therapy - Research on myeloma therapy described by scientists at Princess Margaret Hospital
Pneumonia Therapy - Findings in pneumonia therapy reported from A.A. El Solh and co-researchers
Pneumonia Therapy - New pneumonia therapy study findings reported from Chang Gung Memorial Hospital, Department of Laboratory Medicine
Pneumonia Therapy - Research from SUNY Downstate Medical Center, Department of Medicine reveals new findings on pneumonia therapy
Pneumonia Therapy - Studies from University of Thessaly, Department of Microbiology add new findings in the area of pneumonia therapy
Pneumonia Therapy - Studies from University of Tsukuba, Institute of Clinical Medicine provide new data on pneumonia therapy
Non-Small Cell Lung Cancer Therapy - Scientists at Hokkaido University, Department of Medicine target non-small cell lung cancer therapy
Abraxis BioScience, Inc. - CORRECTING and REPLACING Abraxis BioScience Completes Enrollment of Pivotal Phase III Advanced Lung Cancer Study Evaluating ABRAXANE® Vs. Taxol®
Bronchitis - Cornerstone Therapeutics Signs Definitive Asset Purchase Agreement to Acquire Commercial Rights to the Antibiotic Factive(R)
Cancer - Beijing Cancer Hospital Becomes First Hospital in Mainland China to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments
Cancer - Exosome Diagnostics and DxS Diagnostic Innovations Collaborate to Develop Blood Based Tests for Key Cancer Mutations
Cancer - Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
Endocyte Inc. - Endocyte to Present Data on EC145 at the IASLC 13th World Conference on Lung Cancer
Gene Therapy - Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks
Medicare and Medicaid - National Advocacy Organization Representing Home Oxygen Patients Praises Introduction of Medicare Home Oxygen Therapy Act
National Jewish Health - National Jewish Health Named Top Respiratory Hospital for 12th Consecutive Year
Non-Small Cell Lung Cancer - Abbott and GSK to Collaborate on Molecular Diagnostic Test to Select Candidate Patients for Future Cancer Immunotherapy
Non-Small Cell Lung Cancer - ALIMTA(R) (pemetrexed for injection) First Agent Approved in Europe as Maintenance Therapy for Advanced, Nonsquamous Non-Small Cell Lung Cancer
Oscient Pharmaceuticals Corporation - Oscient Pharmaceuticals Files Voluntary Petition for Relief Under Chapter 11 of the United States Bankruptcy Code
OSI Pharmaceuticals, Inc. and Genentech, Inc. - New Data from Phase III SATURN Study Showed Tarceva Improved Overall Survival When Used Immediately After Initial Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
Pneumonia - Forest Laboratories Announces Positive Top-line Data from Two Pivotal Phase III Trials of Ceftaroline for the Treatment of Community-acquired Bacterial Pneumonia (CABP) Requiring Hospitalization Ceftaroline Met P